Familial Dysautonomia Clinical Trial
Official title:
Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia
The purpose of this placebo controlled interventional study is to collect preliminary data on administering dexmedetomidine in patients with Familial Dysautonomia (FD) during a rapid cessation of autonomic crisis. The primary aims are to assess the feasibility and evaluate if measurements of heart rate, blood pressure and oxygen saturation can predict the start of an autonomic crisis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT02608931 -
The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia
|
Phase 2 | |
| Completed |
NCT02276716 -
The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia
|
Phase 2 | |
| Completed |
NCT02274051 -
The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia
|
Phase 1 | |
| Completed |
NCT01987219 -
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia
|
Phase 3 | |
| Completed |
NCT01999257 -
Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.
|
N/A | |
| Completed |
NCT03013777 -
A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia
|
N/A | |
| Completed |
NCT01212484 -
Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
|
Phase 3 | |
| Not yet recruiting |
NCT06128356 -
Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia
|
Phase 2 | |
| Withdrawn |
NCT03911063 -
Telemedicine Clinical Trial for Cognitive Behavioral Therapy in Familial Dysautonomia
|
N/A |